MANNKIND CORP

MNKD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $-220.1M
Depreciation & Amortization $18.7M
Depreciation
Amortization
Stock-Based Compensation $20.2M
Net Cash from Operating Activities $-184.1M
Investing Activities
Capital Expenditures $18.9M
Business Acquisitions
Net Cash from Investing Activities $-3.1M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $189.5M
Net Change in Cash $2.4M
Free Cash Flow $-202.9M
← Newer Page 3 of 3 Older →